Company Filing History:
2 out of 1,506 
1 out of 495 
Years Active: 1983-1987
Title: Gary W Morrow: Innovator in Anticancer Antibiotics
Introduction
Gary W Morrow is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer antibiotics. With a total of 3 patents, Morrow's work has the potential to impact cancer treatment significantly.
Latest Patents
Morrow's latest patents include innovative compounds such as 1-fluoro, 4-fluoro, and 1,4-difluoro anthracycline anticancer antibiotics. These compounds are represented by a specific formula where R can be hydrogen or hydroxyl, and one of X and Y is fluorine while the other is hydrogen, or both X and Y are fluorine. The compounds are designed to be useful as anticancer antibiotics, and they also include pharmaceutical preparations that contain these antibiotics. Additionally, a method for inhibiting the growth of mammalian tumors is disclosed. Another patent focuses on 1-fluoro, 4-fluoro, and 1,4-difluoro-2'-halo anthracycline antibiotics, which also follow a similar formula and aim to provide effective treatment options for cancer.
Career Highlights
Throughout his career, Gary W Morrow has worked with reputable organizations, including The Ohio State University and Albany International Corporation. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical field.
Collaborations
Morrow has collaborated with notable colleagues such as John S Swenton and Waldemar A Priebe. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Gary W Morrow's contributions to the field of anticancer antibiotics demonstrate his commitment to innovation and improving cancer treatment. His patents reflect a significant advancement in pharmaceutical research, showcasing the potential for new therapeutic options.